Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
Organizer:

Each day, 37% of new HIV infections occurring beyond childhood are among young people ages 15 to 24 years, due to developmental, biological and social factors that increase their HIV risk. Although efforts are being made to reach youth with oral pre-exposure prophylaxis (PrEP) for HIV prevention, many challenges remain, from identifying youth who may benefit from PrEP, to reaching and retaining youth in services. The World Health Organization has developed an implementation module for those interested in providing PrEP to adolescents and young adults. The tool summarizes factors influencing youth susceptibility to HIV, describes the role of PrEP, outlines enabling policies to improve access, and discusses clinical considerations. This session will bring together a diverse group of scientists, clinicians, policy makers, programme implementers and youth representatives to describe the latest scientific evidence, share experiences, discuss challenges, and highlight best practices for for delivering youth-friendly prevention services that incorporate PrEP.

07:00
TUSA0301
Introduction: Evolving thinking on adolescents, and why youth needs are different from adults
Bill G. Kapogiannis, National Institutes of Health, United States
07:05
TUSA0302
Strategically supporting PrEP implementation for adolescents & young adults
Shona Dalal, World Health Organization (WHO), Switzerland
Slides
07:10
TUSA0303
Current science on providing PrEP to adolescents and young adults
Sinead Delany-Moretlwe, Wits Reproductive Health and HIV Institute (WRHI), South Africa
Slides
07:20
TUSA0304
Panel: Hearing it direct: What are young people looking for, what needs to change?
Linda-Gail Bekker, Desmond Tutu HIV Centre, South Africa
Tamia Julayi, N/A, South Africa
Pich Seekaew, Thai Red Cross AIDS Research Centre, Thailand
Laura Alves, N/A, Brazil
Sibongile Mnisi, N/A, Swaziland
Slides
08:00
TUSA0305
Panel: Hearing from implementers: Boots on the ground for youth
Connie Celum, University of Washington, United States
Irene Mukui, Ministry of Health, Kenya
Nittaya Phanuphak, Thai Red Cross AIDS Research Centre, Thailand
Inês Dourado, Federal University of Bahia, Brazil
Elizabeth Bukusi, Kenya Medical Research Institute (KEMRI), Kenya
Slides
08:25
TUSA0306
Summary and closing remarks
Bill G. Kapogiannis, National Institutes of Health, United States